Initial preclinical investigation of aclarubicin treatment in primary cutaneous T-cell lymphoma cells
JID Innovations
· Elsevier
Аннотация у издателя не опубликована — полный текст доступен по ссылке ниже.
Читать у издателя →
Цитирование
Initial preclinical investigation of aclarubicin treatment in primary cutaneous T-cell lymphoma cells. // JID Innovations. – URL: https://www.sciencedirect.com/science/article/pii/S2667026726000482?dgcid=rss_sd_all
Initial preclinical investigation of aclarubicin treatment in primary cutaneous T-cell lymphoma cells. JID Innovations. https://www.sciencedirect.com/science/article/pii/S2667026726000482?dgcid=rss_sd_all
“Initial preclinical investigation of aclarubicin treatment in primary cutaneous T-cell lymphoma cells.” JID Innovations.
@article{article51289,
title = {Initial preclinical investigation of aclarubicin treatment in primary cutaneous T-cell lymphoma cells},
journal = {JID Innovations},
url = {https://www.sciencedirect.com/science/article/pii/S2667026726000482?dgcid=rss_sd_all}
}